TOPLINE: Once-weekly semaglutide 2.4 mg led to significant decreases in body weight and fat mass over 12 months while preserving lean mass and improved muscle function in adults with obesity. Weight and fat loss were more pronounced in women and in patients with prior bariatric surgery…
Read More
